The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | S | Sensory organs | |
| 2 | S01 | Ophthalmologicals | |
| 3 | S01B | Antiinflammatory agents | |
| 4 | S01BC | Antiinflammatory agents, non-steroids | |
| 5 | S01BC10 | Nepafenac |
| Active Ingredient | Description | |
|---|---|---|
| Nepafenac |
Nepafenac is a non-steroidal anti-inflammatory and analgesic prodrug. After topical ocular dosing, nepafenac penetrates the cornea and is converted by ocular tissue hydrolases to amfenac, a nonsteroidal anti-inflammatory drug. Amfenac inhibits the action of prostaglandin H synthase (cyclooxygenase), an enzyme required for prostaglandin production. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ILEVRO Ophthalmic suspension | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| NEVANAC Eye drops, suspension | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
